下肢血运重建术后手术部位感染的危险因素:预后研究的系统评价与Meta分析
该系统评价与Meta分析纳入50项研究、共271 125例患者,评估下肢血运重建术后手术部位感染(SSI)的校正危险因素,SSI累积发生率为每100例患者12例(95%CI 10-13)。女性、肥胖、慢性阻塞性肺疾病、慢性肢体威胁性缺血、慢性肾脏病、围术期输血、急诊手术、静脉旁路或补片、手术时长≥3小时及早期再手术等均与SSI风险升高相关,证据确定性从中等到高不等。
要点
- SSI累积发生率为每100例患者12例(95%CI 10-13)。
- 肥胖(校正OR 2.20,高确定性)和女性(校正OR 1.41,高确定性)是SSI的危险因素。
- 早期或非计划再手术与SSI风险升高相关(校正OR 4.50,低确定性)。
核心结论
- 该系统评价识别了下肢血运重建术后SSI的证据支持的的危险因素,这些因素可用于开发改进的SSI风险预测工具,并识别可能从证据支持的SSI预防策略中获益的患者。
研究设计与样本
- 系统评价与Meta分析,遵循PRISMA指南,检索MEDLINE、Embase、Evidence Based Medicine Reviews和Cochrane Central Register of Controlled Trials(从建库至2022年4月28日)。
- 纳入报告成人因外周动脉疾病行下肢血运重建术后SSI校正危险因素的研究;共纳入50项研究,n=271 125例患者。
- 采用随机效应模型汇总校正比值比(OR),使用GRADE评估证据确定性。
主要发现
- SSI累积发生率为每100例患者12例(95%CI 10-13)。
- 研究报道了139个潜在SSI危险因素,校正的中位混杂因素数为12个(范围1-69)。
- 女性(汇总校正OR 1.41,95%CI 1.20-1.64;高确定性)、功能状态依赖(汇总校正OR 1.18,95%CI 1.03-1.35;低确定性)、超重(汇总校正OR 1.82,95%CI 1.29-2.56;中等确定性)、肥胖(汇总校正OR 2.20,95%CI 1.44-3.36;高确定性)、病态肥胖(汇总校正OR 1.65,95%CI 1.08-2.52;中等确定性)与SSI风险升高相关。
- 慢性阻塞性肺疾病(汇总校正OR 1.42,95%CI 1.17-1.71;高确定性)、慢性肢体威胁性缺血(汇总校正OR 1.67,95%CI 1.22-2.29;中等确定性)、慢性肾脏病(汇总校正OR 2.13,95%CI 1.18-3.83;中等确定性)、术中输血(汇总校正OR 1.23,95%CI 1.02-1.49;中等确定性)、围术期输血(汇总校正OR 1.92,95%CI 1.27-2.90;中等确定性)、术后输血(汇总校正OR 2.21,95%CI 1.44-3.39;中等确定性)与SSI风险升高相关。
- 急诊或紧急手术(汇总校正OR 2.12,95%CI 1.22-3.70;中等确定性)、静脉旁路和或补片而非单纯动脉内膜切除术(汇总校正OR 1.86,95%CI 1.33-2.59;中等确定性)、手术时长≥3小时(汇总校正OR 1.86,95%CI 1.33-2.59;中等确定性)或≥5小时(汇总校正OR 1.60,95%CI 1.18-2.17;中等确定性)、早期或非计划再手术(汇总校正OR 4.50,95%CI 2.18-9.32;低确定性)与SSI风险升高相关。
临床怎么用
- 原文结论指出,这些证据支持的SSI危险因素可用于开发改进的SSI风险预测工具,并识别可能从证据支持的SSI预防策略中获益的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To systematically review and meta-analyse adjusted risk factors for surgical site infection (SSI) after lower limb revascularisation surgery. DATA SOURCES: MEDLINE, Embase, Evidence Based Medicine Reviews, and the Cochrane Central Register of Controlled Trials (inception to 28 April 2022). REVIEW METHODS: Systematic review and meta-analysis conducted according to PRISMA guidelines. After protocol registration, databases were searched. Studies reporting adjusted risk factors for SSI in adults who underwent lower limb revascularisation surgery for peripheral artery disease were included. Adjusted odds ratios (ORs) were pooled using random effects models. GRADE was used to assess certainty. RESULTS: Among 6 377 citations identified, 50 studies (n = 271 125 patients) were included. The cumulative incidence of SSI was 12 (95% confidence interval [CI] 10 - 13) per 100 patients. Studies reported 139 potential SSI risk factors adjusted for a median of 12 (range 1 - 69) potential confounding factors. Risk factors that increased the pooled adjusted odds of SSI included: female sex (pooled OR 1.41, 95% CI 1.20 - 1.64; high certainty); dependent functional status (pooled OR 1.18, 95% CI 1.03 - 1.35; low certainty); being overweight (pooled OR 1.82, 95% CI 1.29 - 2.56; moderate certainty), obese (pooled OR 2.20, 95% CI 1.44 - 3.36; high certainty), or morbidly obese (pooled OR 1.65, 95% CI 1.08 - 2.52; moderate certainty); chronic obstructive pulmonary disease (pooled OR 1.42, 95% CI 1.17 - 1.71; high certainty); chronic limb threatening ischaemia (pooled OR 1.67, 95% CI 1.22 - 2.29; moderate certainty); chronic kidney disease (pooled OR 2.13, 95% CI 1.18 - 3.83; moderate certainty); intra-operative (pooled OR 1.23, 95% CI 1.02 - 1.49), peri-operative (pooled OR 1.92, 95% CI 1.27 - 2.90), or post-operative (pooled OR 2.21, 95% CI 1.44 - 3.39) blood transfusion (moderate certainty for all); urgent or emergency surgery (pooled OR 2.12, 95% CI 1.22 - 3.70; moderate certainty); vein bypass and or patch instead of endarterectomy alone (pooled OR 1.86, 95% CI 1.33 - 2.59; moderate certainty); an operation lasting ≥ 3 hours (pooled OR 1.86, 95% CI 1.33 - 2.59; moderate certainty) or ≥ 5 hours (pooled OR 1.60, 95% CI 1.18 - 2.17; moderate certainty); and early or unplanned re-operation (pooled OR 4.50, 95% CI 2.18 - 9.32; low certainty). CONCLUSION: This systematic review identified evidence informed SSI risk factors following lower limb revascularisation surgery. These may be used to develop improved SSI risk prediction tools and to identify patients who may benefit from evidence informed SSI prevention strategies.
引用
- Kirkham AM, Candeliere J, Mai T, et al. Risk Factors for Surgical Site Infection after Lower Limb Revascularisation Surgery: a Systematic Review and Meta-Analysis of Prognostic Studies. Eur J Vasc Endovasc Surg. 2023. PMID: 37925099. doi:10.1016/j.ejvs.2023.10.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。